Christian Pangratz appointed CEO of sterna biologicals

Clinical-stage Immunology Company asserted appointment of Sterna Biologicals as the Chief Executive Officer who has over 25 years of experience in life science specifically in areas of strategic planning, corporate and business development, alliance and project management.

Jonas Renz, Managing Director of sterna biological, stated “Christian is a proven senior executive with extensive leadership experience and an impressive track record. He was instrumental in a number of successful business transformations and high-value transactions across various therapeutic areas that are highly relevant to sterna.”

Prior to this, Christian Pangratz was Senior Vice President of Business Development at Ventura Group plc. He also served as Non-Executive Director on the Board of Directors of Skyepharma AG and Jagotec AG, and on the Board of Directors of Tianjin Kinnovata Pharmaceutical Co. Ltd., from 2014 to 2016; Mr. Pangratz was Executive Vice President of Business Development, Alliance Management & Project Management at Skyepharma in Basel, Switzerland. Prior to this, he served as Chief Business Officer at Activaero, a German-American respiratory company.